Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Liraglutide for Sale > Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides Powder 204656-20-2
Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2 buy - large image1
Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2 buy - image1
Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2 buy - image2
Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2 buy - image3
Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2 buy - image4
Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2 buy - image5
Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2 buy - image6

Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides Powder 204656-20-2

TDS 29 Inquiries

Unit Price: Get Latest Price
CAS No.:

204656-20-2

Grade:

Industrial Grade

Content:

99%

Port:

shenzhen

Brand:

csxj

Packaging:

1000kg

Price valid (until):

2025-07-20

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Semaglutide,Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Name:Nico
    Telegram:+852 5420 7247
    Whatsapp:+852 5421 6024
    Email Address:sales002@chjunxi.com


    Product Detail  


    Liraglutide is a long-acting GLP-1 receptor agonist with 97% amino acid sequence homology to endogenous human GLP-1. It enhances glucose-dependent insulin secretion, suppresses glucagon release, and delays gastric emptying. Clinically approved for:

    • Type 2 Diabetes (T2DM): Glycemic control in adults (monotherapy or combined with metformin/sulfonylureas) 49.

    • Chronic Weight Management: Adjunct therapy for obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with weight-related comorbidities (e.g., hypertension, prediabetes)

    • Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 1 Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 2


    Product Attributes & Specifications


    Attribute Specification
    CAS Number 204656-20-2
    Molecular Formula C₁₇₂H₂₆₅N₄₃O₅₁
    Appearance Colorless to nearly colorless solution
    pH 8.15
    Administration Once-daily subcutaneous injection
    Storage 2–8°C (unopened); ≤30°C (in-use, ≤30 days)
    Half-life 13 hours



    • Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 3


      Key Functions


      • common to various degrees with other GLP-1 receptor agonists,liraglutide has advantages over more traditional therapies for type 2 diabetes:
        1. Liraglutide acts in a glucose-dependent manner, meaning Liraglutide will stimulate insu.lin secretion only when blood glucose levels are higher than normal, preventing "overshoot".Consequently, Liraglutide shows negligible risk of hypoglycemia.
        2. Liraglutide has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies).
        3. Liraglutide decreases appetite and inhibits body weight gain,as shown in a head-to-head study versus glimepiride.
        4. Liraglutide lowers blood triglyceride levels.

      • Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 4


    Applications


    1. T2DM Management:

      • First-line or add-on therapy for adults inadequately controlled by oral agents 49.

    2. Obesity Treatment:

      • Long-term weight management in adults/adolescents (≥12 years, BMI ≥30 kg/m²) with lifestyle intervention 17.

    3. Metabolic Syndrome:

      • Improves lipid profiles, reduces liver fat, and lowers hypertension risk 10.

    4. Research Areas:

      • Potential neuroprotection (Alzheimer’s), NAFLD/NASH, and bipolar disorder with obesity

      • Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 5


    Safety & Compliance


    • Common Side Effects: Nausea (~40%), vomiting, diarrhea (usually transient) 39.

    • Contraindications:

      • Thyroid C-cell carcinoma history, pancreatitis, severe renal/hepatic impairment 37.

    • Special Populations:

      • Not recommended for pregnancy, lactation, or children <12 years 9.

    ⚠️ Regulatory Note: For research or pharmaceutical use only. Not for direct human consumption without medical supervision.

    Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 6


    Indications  


    Improve blood sugar in adults with type 2 diabetes.
    As a weight loss drug for adults who are obese (BMI 30 or above) or overweight (BMI 27 or above but with at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or high cholesterol), with Manage your weight by reducing dietary calories and increasing exercise.

    Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 7


      Storage conditions  


    Should be stored in the refrigerator at 2°C to 8°C, away from light.

    If required, each single-dose pen can be stored unrefrigerated at a temperature not exceeding 30°C for up to 21 days, but once stored at room temperature it should not be returned to the refrigerator. If not used within 21 days after removal from the refrigerator, it should be discarded. Do not freeze tilpotide and if frozen, do not use.

    Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 8


    Product packaging


    2mg/vial,10vials/box;

    5mg/vial,10vials/box;

    10mg/vial,10vials/box;

    15mg/vial,10vials/box;

    20mg/vial,10vials/box;

    30mg/vial,10vials/box;

    40mg/vial,10vials/box;

    50mg/vial,10vials/box;

    60mg/vial,10vials/box;

    80mg/vial,10vials/box

    Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 9 Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 10


    logistics 


    Ship according to the customer's choice and deliver to the door.

    Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 11

    Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 12


    Company Profile 


    Changsha XiJun Co., Ltd.

    High-Tech Peptide Innovator

    Based in Changsha, Hunan, we are a dynamic biotech enterprise focused on R&D and production of premium peptide products for pharmaceutical, nutraceutical, and cosmetic applications.

    Core Strengths:

    • Advanced peptide technology

    • Rigorous quality control (cGMP standards)

    • Expert R&D team

    • End-to-end solutions from raw materials to finished products

    Mission:
    "Technology Powers Health, Quality Defines the Future" — advancing global wellness through cutting-edge peptide science.

    Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 13 Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 14 Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 15 Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 16


    Why choose us?


    1. We has a professional RESEARCH and development team and strong technical force to ensure technical support and research capabilities.

    2. Made in China and exported to many countries and regions at the most favorable price.
    3,Our customers all over the world and have been highly valued and trusted by customers

    4,We promise to reply your inquiry within 24 hours, including holidays and holidays.

    5, safe and prudent shipping a variety of transportation modes for you to choose.

    Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 17

    Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 18


    Certificate


    Shop Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2-Detailed Image 19


    Welcome to inquire


    ECHEMI Editorial Reference
    Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
    Liraglutide is characterized as a white to almost white powder. It is freely soluble in aqueous base solutions (> 270 mg/mL), but its water solubility decreases below pH 7 and reaches its lowest level at pH 4-5 (approximately 0.05 mg/mL). Solubility increases marginally at pH 2.5 where it is very slightly soluble (≤ 0.8 mg/mL). Liraglutide is soluble in methanol (68 mg/mL) and very slightly soluble in ethanol (1.1 mg/mL). The isoelectric point of liraglutide is approximately 4.9. The pH of a 1 mg/mL aqueous solution of drug substance is approximately 9.3.
    ChEBI: Liraglutide, a lipopeptide and polypeptide, is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Liraglutide functions as a glucagon-like peptide-1 receptor agonist and serves as a neuroprotective agent.
    Liraglutide is GLP-1(1–37) modified at Ly: the -amino group is acylated with an (N-hexadecanoyl)glutam- -yl moiety that noncovalently but avidly binds tohuman serum albumin. (Also, Lys is conservatively replacedwith Arg.) These changes provide for a greatly extendedserum t12 of~10 to 15 hours after sc administration(0.6–1.8 mg), allowing for once-daily dosing.Liraglutide (Victoza, Novo Nordisk) is awaiting approvalby the FDA, EMEA, and the Koˉ roˉ -shoˉ (Japan).
    Liraglutide peptide is a single, non-glycosylated polypeptide chain containing 31 amino acids, having a molecular mass of 3751 Dalton and a Molecular formula of C172H265N43O51.

    Certificates
    • Liraglutide High Quality GMP / FDA Certificated Liraglutide Peptides  Powder  204656-20-2 Certificates 1 TDS

    Basic Info
    Product Name:

    Liraglutide

    Other Name:

    Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide

    CAS No.:

    204656-20-2

    Molecular Formula:

    C172H265N43O51

    InChIKeys:

    YSDQQAXHVYUZIW-VTFFJMQZNA-N

    Molecular Weight:

    3751.202

    Exact Mass:

    3748.95000

    EC Number:

    810-818-7

    Color/Form:

    White to Off-White

    Categories:

    Polypeptide

    Characteristics
    PSA:

    1513.76000

    XLogP3:

    6.12960

    Melting Point:

    >182°C (dec.)

    Critical Temperature & Pressure:

    Refrigerator

    Research
    Class:

    GLP-1 receptor agonist (acylated GLP-1 analog, 31-amino-acid peptide)

    Status:

    FDA-approved (Victoza 2010, Saxenda 2014 for obesity)

    Mechanism:

    A 31-amino-acid GLP-1 analog with a C16 fatty-acid chain (palmitoyl) attached to Lys26 via a gamma-glutamic acid spacer. This fatty-acid modification enables reversible binding to serum albumin, extending the half-life to ~13 hours and allowing once-daily dosing. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite.

    EC50 (GLP1R Ec50):

    ~10 nM

    Source:

    DrugBank: DB06655; Knudsen LB, et al. J Med Chem. 2000;43(9):1664-1669.DOI

    Clinical Development:

    NCT00781922; NCT01272219

    FDA:

    Victoza, Saxenda (approved 2010-01-25)

    References
    ChEMBL:

    CHEMBL1213363

    DrugBank:

    DB06655

    KEGG DRUG:

    D09199

    PubChem:

    PubChem

    Disclaimer:

    Liraglutide is FDA-approved as a prescription medicine (Victoza for T2DM, Saxenda for obesity). This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide,Retatrutide

    Location:

    Room 1232-1237, 12th Floor, Yilv Building, No. 255, Xiangzhang Road, Jingwanzi Street, Yuhua District, Changsha City, Hunan Province - 2772

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    51-100

    Year of Establishment:

    2023

    Changsha Xjun Technology Co., Ltd.was established in 2023 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs and  pharmaceutical.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has received cooperation orders from several well-known foreign pharmaceutical companies.

  • Inquiry History
    29 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    China factory wholesale price supply high purity 99% cas 204656-20-2 Liraglutide injection

    50 KG Sep 30, 2023
    India

    Liraglutide

    1.00 KG Oct 8, 2024
    India

    Liraglutide-USP

    150.00 G Oct 10, 2023
    United Kingdom

    Liraglutide

    20 MG Jul 8, 2026
    United States

    Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta

    50 MG Mar 4, 2026
    India

    liraglutide

    1 KG Feb 25, 2026
    United States

    liraglutide

    Jan 21, 2026
    United States

    liraglutide

    1 MT Nov 22, 2025
    Reunion Island

    Liraglutide

    1 G Apr 14, 2025
    United States

    Liraglut

    1 MT Feb 9, 2025
    Israel

    Liraglutide

    1 G Aug 26, 2024
    India

    Liraglutide

    10 G Jun 26, 2024
    India

    Liraglutide

    100 G Mar 4, 2024
    United States

    Semaglutide Liraglutide powder

    10 G Feb 20, 2024
    United States

    MIC

    2 MT May 20, 2026
    Canada

    Liraglutide

    1 KG Dec 8, 2025
    Brazil

    Liraglutida

    1 G Sep 29, 2025
    United States

    Liraglutide

    1 KG Aug 13, 2025
    Sweden

    liraglutide

    1 KG Aug 4, 2025
    Pakistan

    liraglutide injection

    50 KG Jan 21, 2025
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.